Table 4.
Other Outcomes in Delabeled Versus Non-delabeled Patients (Unadjusted Results and Using Propensity Score)
| Delabeled (n = 355) |
Non-delabeled (n = 870) |
Unadjusted, Not Propensity Score Delabeled vs Non-delabeled | Propensity Score IPTW Delabeled vs Non-delabeled | |||
|---|---|---|---|---|---|---|
| Outcome | Median (IQR) | Median (IQR) | IRR (95% CI) | P Value | IRR (95% CI) | P Value |
| Hospital admission | ||||||
| Length of stay, d | 3 (2–7) | 3 (1–6) | 1.13 (1.00–1.29) | .050 | 1.13 (.93–1.38) | .210 |
| Duration of IV antibiotics, d, index posttesting | 0 (0–1) | 0 (0–0) | 1.05 (.75–1.45) | .792 | 1.29 (.84–1.98) | .238 |
| Duration of IV antibiotics, d, 90 days posttesting | 0 (0–2) | 0 (0–1) | 1.13 (.86–1.48) | .384 | 1.32 (.90–1.92) | .152 |
| Mortality | No. (%) | No. (%) | OR (95% CI) | P Value | OR (95% CI) | P Value |
| In-hospital mortality | 7 (2.0) | 18 (2.1) | 0.95 (.39–2.30) | .911 | 0.85 (.31–2.31) | .754 |
| 90-d mortality | 13 (3.7) | 43 (4.9) | 0.73 (.39–1.38) | .330 | 0.70 (.35–1.37) | .298 |
| Readmissions within 90 d | ||||||
| Any readmissiona | 107 (30.1) | 270 (31) | 0.96 (.73–1.26) | .772 | 0.92 (.69–1.24) | .594 |
| Any readmission with infective diagnosis | 104 (12) | 46 (13) | 1.22 (.78–1.93) | .385 | 1.22 (.74–1.99) | .435 |
Abbreviations: CI, confidence interval; IPTW, inverse probability of treatment weighting; IQR, interquartile range; IRR, incidence rate ratio; IV, intravenous; OR, odds ratio.
aOverall, 10.6% (n = 129; 90 nondelabeled and 39 delabeled) had > 1 readmission.